DK1027437T3 - Anvendelse af det WNT-1 inducerede udskilte polypeptid WISP-1 - Google Patents

Anvendelse af det WNT-1 inducerede udskilte polypeptid WISP-1

Info

Publication number: DK1027437T3
Authority: DK; Denmark
Prior art keywords: wnt; polypeptides; induced; secreted polypeptide; induced secreted
Prior art date: 1997-10-29

Application number

DK98956340T

Other languages

English (en)

Inventor

Kenneth Hillan

David A Lawrence

Diane Pennica

Margaret Ann Roy

Audrey Goddard

William I Wood

Austin L Gurney

David A Botstein

Robert L Cohen

Arnold J Levine

Original Assignee

Genentech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-29

Filing date

1998-10-29

Publication date

2008-11-24

1998-10-29 Application filed by Genentech Inc filed Critical Genentech Inc

2008-11-24 Application granted granted Critical

2008-11-24 Publication of DK1027437T3 publication Critical patent/DK1027437T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/74—Inducing cell proliferation
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Genetics & Genomics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Oncology (AREA)
Toxicology (AREA)
Analytical Chemistry (AREA)
Pathology (AREA)
Gastroenterology & Hepatology (AREA)
Wood Science & Technology (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Cell Biology (AREA)
Microbiology (AREA)
Communicable Diseases (AREA)
Physics & Mathematics (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Hospice & Palliative Care (AREA)
Dermatology (AREA)
Reproductive Health (AREA)
Rheumatology (AREA)

DK98956340T 1997-10-29 1998-10-29 Anvendelse af det WNT-1 inducerede udskilte polypeptid WISP-1 DK1027437T3 (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US6370497P	1997-10-29	1997-10-29
US7361298P	1998-02-04	1998-02-04
US8169598P	1998-04-14	1998-04-14
PCT/US1998/022991 WO1999021998A1 (en)	1997-10-29	1998-10-29	Wnt-1 induced secreted polypeptides: wisp-1, -2 and -3

Publications (1)

Publication Number	Publication Date
DK1027437T3 true DK1027437T3 (da)	2008-11-24

Family

ID=27370521

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK98956340T DK1027437T3 (da)	1997-10-29	1998-10-29	Anvendelse af det WNT-1 inducerede udskilte polypeptid WISP-1

Country Status (11)

Country	Link
US (5)	US6387657B1 (da)
EP (2)	EP1027437B8 (da)
JP (3)	JP2003533164A (da)
AT (1)	ATE406441T1 (da)
AU (2)	AU1288399A (da)
CA (1)	CA2306183A1 (da)
DE (1)	DE69839942D1 (da)
DK (1)	DK1027437T3 (da)
ES (1)	ES2313756T3 (da)
IL (2)	IL135704A (da)
WO (1)	WO1999021998A1 (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040132987A1 (en) *	1996-11-08	2004-07-08	Human Genome Sciences, Inc.	Connective tissue growth factor-3
DK1027437T3 (da) *	1997-10-29	2008-11-24	Genentech Inc	Anvendelse af det WNT-1 inducerede udskilte polypeptid WISP-1
US6395890B1 (en)	1998-02-20	2002-05-28	Zymogenetics, Inc.	Nucleic acids encoding connective tissue growth factor homologs
WO1999042583A1 (en) *	1998-02-20	1999-08-26	Zymogenetics, Inc.	Connective tissue growth factor homologs
AU3357799A (en) *	1998-03-19	1999-10-11	Trustees Of Tufts College	Novel heparin-induced ccn-like molecules and uses therefor
AU4411499A (en) *	1998-06-05	1999-12-20	Human Genome Sciences, Inc.	Connective tissue growth factor-4
US20030148934A1 (en) *	1998-06-30	2003-08-07	Neil C. Corley	Growth factor modulators
US7740841B1 (en) *	2000-01-28	2010-06-22	Sunnybrook Health Science Center	Therapeutic method for reducing angiogenesis
US7097840B2 (en)	2000-03-16	2006-08-29	Genentech, Inc.	Methods of treatment using anti-ErbB antibody-maytansinoid conjugates
AU2437702A (en) *	2000-10-16	2002-04-29	Genentech Inc	Methods of treatment using wisp polypeptides
US7713526B2 (en) *	2001-05-01	2010-05-11	The Regents Of The University Of California	Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
AU2002308557A1 (en) *	2001-05-01	2002-11-11	The Regents Of The University Of California	Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
CA2489515C (en) *	2002-06-29	2013-01-22	Genentech, Inc.	Methods and compositions for modulating and detecting wisp activity
US7455834B2 (en) *	2002-06-29	2008-11-25	Genentech, Inc.	Methods and compositions for modulating and detecting WISP activity
US8088387B2 (en)	2003-10-10	2012-01-03	Immunogen Inc.	Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
NZ549040A (en)	2004-02-17	2009-07-31	Schering Corp	Use for interleukin-33 (IL33) and the IL-33 receptor complex
EP2812350B1 (en)	2012-02-11	2019-04-03	F.Hoffmann-La Roche Ag	R-spondin translocations and methods using the same
GR1008033B (el) *	2012-03-29	2013-11-18	Βασιλειος Τσιλιβακος	Μεθοδος διερευνησης της παρουσιας ενδοκυτταριων μολυσματικων παραγοντων σε κυτταρα του σπερματος
TWI582239B (zh) *	2013-03-11	2017-05-11	諾華公司	與ｗｎｔ抑制劑相關之標記
JP2017513854A (ja) *	2014-04-15	2017-06-01	ソレント・セラピューティクス・インコーポレイテッドＳｏｒｒｅｎｔｏＴｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ．	Ｗｉｓｐ１に結合する抗原結合タンパク質
JP7240749B2 (ja) *	2017-09-29	2023-03-16	ベスファジェン・インコーポレイテッド	心不全の予防または治療のための医薬組成物
US10831733B2 (en) *	2017-12-22	2020-11-10	International Business Machines Corporation	Interactive adjustment of decision rules
JP7264382B2 (ja) *	2018-05-17	2023-04-25	オリーブスバイオセラピューティクスインコーポレイテッド	網膜疾患を予防又は治療するための、有効成分としてｃｃｎ５を含む医薬組成物
US20210388073A1 (en) *	2018-10-19	2021-12-16	The General Hospital Corporation	Compositions and Methods for Treatment of Liver Disease
WO2023055076A1 (ko) *	2021-09-29	2023-04-06	이화여자대학교 산학협력단	암 전이 억제용 조성물
WO2023182792A1 (ko) *	2022-03-24	2023-09-28	이화여자대학교 산학협력단	암 성장 억제용 조성물
WO2025160400A1 (en) *	2024-01-26	2025-07-31	Mediar Therapeutics, Inc.	Therapeutic antibody targeting wisp1 protein

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3720760A (en)	1968-09-06	1973-03-13	Pharmacia Ab	Method for determining the presence of reagin-immunoglobulins(reagin-ig)directed against certain allergens,in aqueous samples
US3773919A (en)	1969-10-23	1973-11-20	Du Pont	Polylactide-drug mixtures
US4179337A (en)	1973-07-20	1979-12-18	Davis Frank F	Non-immunogenic polypeptides
US4275149A (en)	1978-11-24	1981-06-23	Syva Company	Macromolecular environment control in specific receptor assays
US4318980A (en)	1978-04-10	1982-03-09	Miles Laboratories, Inc.	Heterogenous specific binding assay employing a cycling reactant as label
JPS6023084B2 (ja)	1979-07-11	1985-06-05	味の素株式会社	代用血液
DE2946031A1 (de)	1979-11-14	1981-05-21	Zinser Textilmaschinen Gmbh, 7333 Ebersbach	Vorrichtung zum abschalten eines elektromotorischen einzelspindelantriebes bei betriebsstoerung an einer textilmaschine
US4399216A (en)	1980-02-25	1983-08-16	The Trustees Of Columbia University	Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
ZA811368B (en)	1980-03-24	1982-04-28	Genentech Inc	Bacterial polypedtide expression employing tryptophan promoter-operator
US4376110A (en)	1980-08-04	1983-03-08	Hybritech, Incorporated	Immunometric assays using monoclonal antibodies
NZ201705A (en)	1981-08-31	1986-03-14	Genentech Inc	Recombinant dna method for production of hepatitis b surface antigen in yeast
US4640835A (en)	1981-10-30	1987-02-03	Nippon Chemiphar Company, Ltd.	Plasminogen activator derivatives
US4943529A (en)	1982-05-19	1990-07-24	Gist-Brocades Nv	Kluyveromyces as a host strain
US4870009A (en)	1982-11-22	1989-09-26	The Salk Institute For Biological Studies	Method of obtaining gene product through the generation of transgenic animals
US4713339A (en)	1983-01-19	1987-12-15	Genentech, Inc.	Polycistronic expression vector construction
AU2353384A (en)	1983-01-19	1984-07-26	Genentech Inc.	Amplification in eukaryotic host cells
US4816567A (en)	1983-04-08	1989-03-28	Genentech, Inc.	Recombinant immunoglobin preparations
US4675187A (en)	1983-05-16	1987-06-23	Bristol-Myers Company	BBM-1675, a new antibiotic complex
DD266710A3 (de)	1983-06-06	1989-04-12	Ve Forschungszentrum Biotechnologie	Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase
AU3145184A (en)	1983-08-16	1985-02-21	Zymogenetics Inc.	High expression of foreign genes in schizosaccharomyces pombe
US4496689A (en)	1983-12-27	1985-01-29	Miles Laboratories, Inc.	Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US4736866B1 (en)	1984-06-22	1988-04-12		Transgenic non-human mammals
US4879231A (en)	1984-10-30	1989-11-07	Phillips Petroleum Company	Transformation of yeasts of the genus pichia
US4683195A (en)	1986-01-30	1987-07-28	Cetus Corporation	Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4737456A (en)	1985-05-09	1988-04-12	Syntex (U.S.A.) Inc.	Reducing interference in ligand-receptor binding assays
EP0206448B1 (en)	1985-06-19	1990-11-14	Ajinomoto Co., Inc.	Hemoglobin combined with a poly(alkylene oxide)
US4676980A (en)	1985-09-23	1987-06-30	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Target specific cross-linked heteroantibodies
EP0272253A4 (en)	1986-03-07	1990-02-05	Massachusetts Inst Technology	METHOD FOR IMPROVING GLYCOPROTE INSTABILITY.
GB8610600D0 (en)	1986-04-30	1986-06-04	Novo Industri As	Transformation of trichoderma
US4791192A (en)	1986-06-26	1988-12-13	Takeda Chemical Industries, Ltd.	Chemically modified protein with polyethyleneglycol
US4946783A (en)	1987-01-30	1990-08-07	President And Fellows Of Harvard College	Periplasmic protease mutants of Escherichia coli
US5010182A (en)	1987-07-28	1991-04-23	Chiron Corporation	DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides
IL87737A (en)	1987-09-11	1993-08-18	Genentech Inc	Method for culturing polypeptide factor dependent vertebrate recombinant cells
DE3850542T2 (de)	1987-09-23	1994-11-24	Bristol Myers Squibb Co	Antikörper-Heterokonjugate zur Töting von HIV-infizierten Zellen.
GB8724885D0 (en)	1987-10-23	1987-11-25	Binns M M	Fowlpox virus promotors
JPH04501201A (ja)	1987-12-21	1992-03-05	ジ・アップジョン・カンパニー	発芽植物種子類のアグロバクテリウム媒介形質転換
JP3040121B2 (ja)	1988-01-12	2000-05-08	ジェネンテク，インコーポレイテッド	増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法
US5016080A (en)	1988-10-07	1991-05-14	Exar Corporation	Programmable die size continuous array
FR2646437B1 (fr)	1989-04-28	1991-08-30	Transgene Sa	Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
DE394538T1 (de)	1989-04-28	1991-04-11	Rhein Biotech Ges. Fuer Biotechnologische Prozesse Und Produkte Mbh, 4000 Duesseldorf	Hefezellen der schwanniomyces-gattung.
EP0402226A1 (en)	1989-06-06	1990-12-12	Institut National De La Recherche Agronomique	Transformation vectors for yeast yarrowia
ATE144793T1 (de)	1989-06-29	1996-11-15	Medarex Inc	Bispezifische reagenzien für die aids-therapie
FR2649120B1 (fr)	1989-06-30	1994-01-28	Cayla	Nouvelle souche et ses mutants de champignons filamenteux, procede de production de proteines recombinantes a l'aide de ladite souche et souches et proteines obtenues selon ce procede
US5183884A (en)	1989-12-01	1993-02-02	United States Of America	Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor
US5206161A (en)	1991-02-01	1993-04-27	Genentech, Inc.	Human plasma carboxypeptidase B
WO1992020373A1 (en)	1991-05-14	1992-11-26	Repligen Corporation	Heteroconjugate antibodies for treatment of hiv infection
EP0590058B1 (en)	1991-06-14	2003-11-26	Genentech, Inc.	HUMANIZED Heregulin ANTIBODy
US5408040A (en)	1991-08-30	1995-04-18	University Of South Florida	Connective tissue growth factor(CTGF)
WO1993008829A1 (en)	1991-11-04	1993-05-13	The Regents Of The University Of California	Compositions that mediate killing of hiv-infected cells
EP0616812B1 (en)	1993-03-24	1999-11-03	Berlex Biosciences	Combination with anti-hormonal compounds and binding molecules for the treatment of cancer
US5536637A (en)	1993-04-07	1996-07-16	Genetics Institute, Inc.	Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
CA2177061A1 (en)	1993-12-22	1995-06-29	Gideon A. Rodan	Dna encoding the wnt-x growth factor
US5585087A (en)	1994-06-08	1996-12-17	President And Fellows Of Harvard College	Assay for identifying extracellular signaling proteins
US5578179A (en)	1995-07-12	1996-11-26	The Perkin-Elmer Corporation	Method and silicate composition for conditioning silica surfaces
US6458939B1 (en)	1996-03-15	2002-10-01	Millennium Pharmaceuticals, Inc.	Compositions and methods for the diagnosis, prevention, and treatment of neoplastic cell growth and proliferation
US6025539A (en)	1996-04-09	2000-02-15	Mayo Foundation For Medical Education And Research	IL-5 transgenic mouse
DE69634994T2 (de) *	1996-11-08	2006-03-23	Human Genome Sciences, Inc.	Bindegewebs-Wachstumsfaktor 3
US5840569A (en)	1996-12-12	1998-11-24	Incyte Pharmaceuticals, Inc.	Human GTP-binding proteins
US6100060A (en)	1997-05-23	2000-08-08	Smithkline Beecham P.L.C.	Compounds
JP2001517093A (ja) *	1997-06-19	2001-10-02	インサイト・ファーマスーティカルズ・インコーポレイテッド	成長因子様タンパク質をコードするポリヌクレオチド
AU9312198A (en) *	1997-09-17	1999-04-05	Genentech Inc.	Genes amplified in tumours, antibodies against the proteins encoded thereby, andtheir use in diagnosis and treatment of cancer
DK1027437T3 (da) *	1997-10-29	2008-11-24	Genentech Inc	Anvendelse af det WNT-1 inducerede udskilte polypeptid WISP-1
AU2002308557A1 (en)	2001-05-01	2002-11-11	The Regents Of The University Of California	Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas

1998
- 1998-10-29 DK DK98956340T patent/DK1027437T3/da active
- 1998-10-29 CA CA002306183A patent/CA2306183A1/en not_active Abandoned
- 1998-10-29 EP EP98956340A patent/EP1027437B8/en not_active Expired - Lifetime
- 1998-10-29 AT AT98956340T patent/ATE406441T1/de active
- 1998-10-29 WO PCT/US1998/022991 patent/WO1999021998A1/en not_active Ceased
- 1998-10-29 IL IL135704A patent/IL135704A/en not_active IP Right Cessation
- 1998-10-29 US US09/182,145 patent/US6387657B1/en not_active Expired - Lifetime
- 1998-10-29 EP EP08012474A patent/EP2014770A3/en not_active Withdrawn
- 1998-10-29 ES ES98956340T patent/ES2313756T3/es not_active Expired - Lifetime
- 1998-10-29 AU AU12883/99A patent/AU1288399A/en not_active Abandoned
- 1998-10-29 JP JP2000518090A patent/JP2003533164A/ja active Pending
- 1998-10-29 DE DE69839942T patent/DE69839942D1/de not_active Expired - Lifetime
2002
- 2002-03-27 US US10/112,267 patent/US7101850B2/en not_active Expired - Fee Related
2003
- 2003-02-24 AU AU2003201315A patent/AU2003201315B8/en not_active Ceased
2006
- 2006-07-17 US US11/488,375 patent/US20070041964A1/en not_active Abandoned
2008
- 2008-12-16 JP JP2008320202A patent/JP2009165470A/ja active Pending
- 2008-12-16 JP JP2008320203A patent/JP2009159956A/ja active Pending
2009
- 2009-12-29 US US12/648,425 patent/US20100221249A1/en not_active Abandoned
2011
- 2011-03-17 IL IL211788A patent/IL211788A0/en unknown
- 2011-05-26 US US13/117,051 patent/US8350008B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20030068678A1 (en)	2003-04-10
AU2003201315A1 (en)	2003-06-12
IL135704A0 (en)	2001-05-20
AU1288399A (en)	1999-05-17
IL211788A0 (en)	2011-05-31
ES2313756T3 (es)	2009-03-01
AU2003201315A8 (en)	2010-04-08
IL135704A (en)	2008-04-13
WO1999021998A1 (en)	1999-05-06
US20110311540A1 (en)	2011-12-22
CA2306183A1 (en)	1999-05-06
EP1027437A1 (en)	2000-08-16
US20100221249A1 (en)	2010-09-02
EP1027437B8 (en)	2008-10-29
US6387657B1 (en)	2002-05-14
US8350008B2 (en)	2013-01-08
US7101850B2 (en)	2006-09-05
EP1027437B1 (en)	2008-08-27
JP2003533164A (ja)	2003-11-11
US20070041964A1 (en)	2007-02-22
AU2003201315B8 (en)	2010-04-08
DE69839942D1 (de)	2008-10-09
JP2009165470A (ja)	2009-07-30
AU2003201315B2 (en)	2006-03-23
JP2009159956A (ja)	2009-07-23
AU2003201315C1 (en)	2007-03-08
EP2014770A3 (en)	2009-02-18
EP2014770A2 (en)	2009-01-14
ATE406441T1 (de)	2008-09-15

Publication	Publication Date	Title
DK1027437T3 (da)	2008-11-24	Anvendelse af det WNT-1 inducerede udskilte polypeptid WISP-1
ATE447583T1 (de)	2009-11-15	Polypeptide und dafür kodierende nukleinsäure
ATE417063T1 (de)	2008-12-15	Sekretierte transmembranproteine und dafür kodierende nukleinsäuren
PT1386931E (pt)	2006-09-29	Homologo de neurotrimina humana
ATE310810T1 (de)	2005-12-15	Polypeptid und dafür kodierendes nukeinsäure
DK1241251T3 (da)	2008-04-07	Humant prostasin-lignende protein og nukleinsyrer kodende for samme
DE69829417D1 (de)	2005-04-21	Polypeptide und dafür kodierende Nukleinsäure
DK1300417T3 (da)	2006-10-30	Secerneret og transmembrant polypeptid og nucleinsyre kodende derfor
DK1217006T3 (da)	2005-03-21	Polypeptider og nucleinsyrer kodende for samme
ATE290018T1 (de)	2005-03-15	Polypeptid und dafür kodieredes nukleinsäure
DK1241180T3 (da)	2008-12-01	Humant A33 antigen-lignende protein og nucleinsyrer, der koder for dette
DE69926415D1 (de)	2005-09-01	Sekretiertes Polypeptide und dafür kodierende Nukleinsäuren
ATE404585T1 (de)	2008-08-15	Menschliches synaptogyrin-ähnliches protein und dafür kodierende nukleinsäure
ATE405590T1 (de)	2008-09-15	Menschliches hcar-ähnliches protein und dafür kodierende nukleinsäure
DK1191101T3 (da)	2004-10-11	PRO241 polypeptider og nucleinsyre kodende herfor
DK1029046T3 (da)	2009-02-02	WNT-1 inducerbare gener
DK1591452T3 (da)	2008-09-15	Secernerede og transmembrane polypeptider og nukleinsyrer kodende for samme
DE69930422D1 (de)	2006-05-11	Sekretierte und transmembrane Polypeptide und dafür kodierende Nukleinsäuren